English

Brevets

PCT62,081,780 Solid phase synthesis of cyclic amino acid molecules; Hickey J; Mancuso J; Marsault E; Roughton A; Treder AP; Tremblay MC; Yudin AK; Zaretsky S, filed 2014/11

WO 2010/142027 A1 Guanine riboswitch binding compounds and their use as antibiotics; Mulhbacher J; Lafontaine D; Malouin F; Allard M; Marsault E, filed 12/2011

US61/492556 Matriptase inhibitors and uses thereof against orthomyxoviridae infections; Richter M; Colombo E; Leduc R; Marsault E, filed 04/2011.

US 61/442,948 Use of steroid alkaloids as antimicrobial agents against electron transport-deficient microbes and as potentiators for antimicrobial agents against pathogenic bacteria and uses thereof; Mitchell G; Malouin F; Marsault E; Bouarab K, filed 02/2011.

WO 2010/142027 A1; Guanine riboswitch binding compounds and their use as antibiotics; Mulhbacher J; Lafontaine D; Marsault E; Allard M; Malouin F; filed 12/2011.

US 61/349,981; Reagent-free evanescent field-based biosensor; Escher E; Charette P; Carpentier A; Grandbois M; Aimez V; Marsault E; 2010.

EP 1 633 774 B1; Macrocyclic antagonists of the motilin receptor. Fraser GL; Marsault E; Peterson ML; Hoveyda HR; Beaubien S; Benakli K; Déziel R, 2010.

Prov Patent Appl 61307088; Antibiotics and uses thereof. Mulhbacher J; Malouin F; Lafontaine D; Allard M; Marsault E; 2010

PCT/US61/186.669; Antibiotics and uses thereof. Mulhbacher J; Malouin F; Lafontaine D; Allard M; Marsault E, 2009.

US 7,550,431 B2; Spatially defined macrocycles incorporating peptide bond surrogates. Deslongchamps, P; Dory YL; Ouellet L; Villeneuve G; Ramaseshan M; Fortin D; Peterson ML; Hoveyda HR; Beaubien S; Marsault E; Fraser GL; 2009.

US 7,521,420; Macrocyclic antagonists of the motilin receptor. Fraser GL; Marsault E; Peterson ML; Hoveyda HR; Beaubien S; Benakli K; Déziel R (published as US 2005/0054562 & WO 2004/111077); 2009.

PCT/US12/273,638 and PCT/US12/273,648; Processes for intermediates for macrocyclic compounds. Marsault E; Ouellet L; Hoveyda HR; 2008.

PCT/US12/273,648; Intermediates for macrocyclic compounds. Marsault E; Benakli K; Hoveyda HR; Peterson ML; Beaubien S; Ouellet L; Saint-Louis C; Beauchemin S; 2008.

PCT/US12/197,610; Macrocyclic modulators of the ghrelin receptor; Marsault E; Ouellet L; Saint-Louis C; BeaubienS; Benakli K; Hoveyda HR; Peterson ML; Bhat S; 2008.

PCT/US12/197,610; Spatially–defined macrocyclic compounds useful in drug discovery, Deslongchamps P; Dory YL; Peterson ML; Benakli K; Marsault E; Ouellet L; Ramaseshan M; Vézina M; Fortin D; Lan R; Li S; Villeneuve G; HoveydaHR; 2008.

U.S. Pat. 7,452,862; Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists and ghrelin agonists. Deslongchamps P; Dory YL; Peterson ML; Benakli K; Marsault E; Ouellet L; Ramaseshan M; Vézina M; Fortin D; Lan R; Li S; Villeneuve G; Hoveyda HR; Beaubien S; Fraser GL; 2008.

US Pat Appl 12/122,094; Macrocyclic antagonists of the motilin receptor for modulation of the migrating motor complex. Marsault E; Fraser GL; Benakli K; Saint-Louis, C; Rouillard A; Thomas H (published as US 2008/0287371), 2008.

PCT/US12028611 & PCT/US2008/001754; Macrocyclic Modulators of the Ghrelin Receptor and Methods of Using the Same; Hoveyda HR; Fraser GL; Beauchemin S; Brassard M; Drutz D; Marsault E; Ouellet L; Peterson ML; Wang Z; 2008.

PCT/US2007/017905; Macrocyclic antagonists of the motilin receptor for treatment of gastrointestinal dysmotility disorders, Marsault E; Fraser GL; Benakli K; Saint-Louis C; Rouillard A; Thomas H (published as WO 2998/03332811); 2007.

US Pat. Appl. 12/122,094; Macrocyclic Antagonists of the Motilin Receptor for Modulation of the Migrating Motor Complex, Marsault E; Fraser GL; (published as US 2008/0287371); 2008.

US Prov. Appl. 60/889,163; Macrocyclic Ghrelin Receptor Modulators and Methods of Using the Same, Hoveyda HR; Fraser GL; Benakli K; Beauchemin S; Brassard M; Marsault E; Ouellet L; Peterson M; Wang Z; 2007.

WO 2004/111077; Preparation of Macrocyclic Antagonists of the Motilin Receptor. Fraser GL; Marsault E; Peterson ML; Hoveyda HR; Beaubien S; Benakli K; 2004.

EU Pat 1,648,923; Preparation of spatially-defined macrocycles incorporating peptide bond surrogates. Deslongchamps P; Dory YL; Ouellet L; Villeneuve G; Ramaseshan M; Fortin D; Peterson ML; Hoveyda HR; Beaubien S; Fraser GL; Marsault E (published as US 2005/0119169 & WO 2005/012332), 2004.

US 6,649,627; Phenoxypropanolamines, method for the production thereof and pharmaceutical compositions containing the same. Cecchi RC, Crocci T; Guzzi U; Marsault E, 2003.

US 6,476,216; Preparation of phosphorothioate oligomers. Just, G.; Xin, Z; Marsault E; Wang J; 2002.

US 6,160,109; Preparation of phosphorothioate and boranophosphate oligomers.Just G; Xin Z; Marsault E; Wang J; Manoharan M; 2000.

US 5,734,041; Preparation of oligodeoxynucleotide phosphorothioates using substituted imidazole-catalyzed coupling. Just G; Xin Z; Marsault E; Wang J; 2000.

US 6,031,092; Preparation of phosphorothioate oligomers. Just G; Xin Z; Marsault E; Wang J; 2000.

PCT WO9965895; Phenoxypropanolamines as beta 3-adrenergic agonists. Cecchi R; Crocci T; Guzzi U; Marsault E; 1999.

US 5,945,521; Preparation of phosphorothioate oligomers. Just G; Xin Z; Marsault E; Jin Y; 1999.

US 5,734,041; Preparation of chiral phosphorothioate oligomers. Just G; Xin Z; Marsault E; Jin Y; 1998.